Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer

Publisher： Karger

E-ISSN： 1423-0232|90|2|59-68

ISSN： 0030-2414

Source： Oncology, Vol.90, Iss.2, 2016-0, pp. : 59-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarkers for early detection of ovarian cancer

By Nguyen Long   Cardenas-Goicoechea Segundo Joel   Gordon Pierre   Curtin Christina   Momeni Mazdak   Chuang Linus   Fishman David  

Women's Health, Vol. 9, Iss. 2, 2013-03 ,pp. : 171-187

Future Medicine

Access to resources Recommend Favorite

Thymidylate Synthase Expression in Epithelial Ovarian Cancer: Relationship with Thymidine Phosphorylase Expression and Prognosis

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 152-157

Karger

Access to resources Recommend Favorite

Molecular Signatures of Ovarian Cancer: From Detection to Prognosis

By Walsh Christine S.   Karlan Beth Y.  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 1, 2010-02 ,pp. : 13-22

Adis International

Access to resources Recommend Favorite

Evolving role of serum biomarkers in the management of ovarian cancer

By Gadducci Angiolo   Cosio Stefania   Zanca Giulia   Genazzani Andrea Riccardo  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 141-158

Future Medicine

Access to resources Recommend Favorite

Elevated VEGF concentrations in ascites and serum predict adverse prognosis in ovarian cancer

By Liang Bin   Guo Zhengdong   Li Yunhui   Liu Chuan  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 73, Iss. 4, 2013-06 ,pp. : 309-314

Informa Healthcare

Access to resources Recommend Favorite